Robin Denise Kent, PA/C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 700 N Hwy 78, Leonard, TX 75452 Phone: 903-587-0287 Fax: 903-587-0298 |
News Archive
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
From Friday 27 August additional support will be deployed to some local authorities in the South West of England.
A new study shows that while the Greater Toronto Area has significantly reduced some of the toxins that contribute to smog, the city continues to violate the Canada-wide standards for ozone air pollution.
Today, MEDRAD, Inc. and Pinestar Technology, Inc. announced plans to enable data communication between MEDRAD's Intego™ PET Infusion System and Pinestar's Nuclear Medicine Information System (NMIS). The companies are closing the information gap between state of the art infusion systems and the latest information systems, and thus adding to the workflow benefits of automated FDG infusion.
Soon scientists will be able to perform efficient DNA analysis right at their bench.
› Verified 6 days ago